Genetic testing

Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms – Christopher Semsarian & Carolyn Ho

2019-07-26T10:25:44+10:00Cardiovascular disease, Genetic testing, Publications|

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder which can present at any age. Although the prevalence is estimated to be 1 in 500 in adults, it is far less common in young children. HCM is frequently caused by pathogenic variants in the sarcomere genes [...]

Go to Top